News Conference News TCT 2021 TAVI Edges Out Surgery in 2-Year Costs for Low-risk Patients: PARTNER 3 Yael L. Maxwell November 05, 2021
News Conference News TCT 2020 No Cost Savings With Routine FFRCT for New-Onset Chest Pain: FORECAST Michael O'Riordan October 21, 2020
News Conference News TCT 2019 MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis Shelley Wood September 29, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Opinion Editor's Corner TCT 2019 TCT 2019 Day Four: Costs and Quality of Life Take Center Stage Shelley Wood September 29, 2019
News Conference News TCT 2019 Strokes Increasing in STEMI Patients With Cardiogenic Shock Todd Neale September 25, 2019
News Conference News TCT 2018 TALENT: Indian-Made Supraflex DES Stands Up Well Against Xience in All-Comers Todd Neale September 22, 2018
News Conference News TCT 2017 FAME 2 at 3 Years: Outcomes, Symptoms Better With PCI vs OMT in Stable CAD, at Similar Cost L.A. McKeown November 02, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
News Conference News TCT 2015 Cath Lab Economics: Pursuit of a Light at the End of the Tunnel Nicole Lou October 11, 2015
News Conference News TCT 2014 Economics May Lead to Shift in Process of Innovation September 15, 2014
News Conference News TCT 2013 Regulatory Hurdles Pose Challenges for Device Approvals in US, Europe October 30, 2013
News Conference News TCT 2013 SYNTAX Cost-effectiveness Analysis Supports Existing Guidelines October 29, 2013
News Conference News TCT 2012 Extended EVEREST II Data Examine Safety, Efficacy of MitraClip as Well as Cost Effectiveness October 25, 2012
News Conference News TCT 2012 FAME 2: FFR-Guided PCI Cost Effective vs. Medical Therapy October 24, 2012